Burning Rock Biotech
BNR | NASDAQ
$12.74
-$0.55 (-4.14%)
At close: Nov 16, 2026, 4:00 PM ET
$12.74
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-4.14%
(1D)No price chart data available for 1D timeframe.
Rating
35.2
Fundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #638/1021 (Top 62%)
Key Statistics
Market Data
Market Cap $13.98M
1D Range
12.41 13.25
52W Range
7.04 41.06
Valuation (TTM)
PE -1.39
PB 0.19
EV/EBITDA 6.61
Valuation (NTM)
Forward PE N/A
Forward PEG -0.04
Price Target $0.00
Cash Flow
FCF Yield -18.8%
SBC Adj. FCF Yield -28.2%
SBC Impact -50.1%
Margins
Gross Margin 74.5%
Operating Margin -13.0%
FCF Margin -3.5%
Growth (CAGR)
Revenue 3Y | 5Y -5.1% |
0.5%
Dil EPS 3Y | 5Y 97.5% |
47.7%
FCF 3Y | 5Y 79.6% |
61.6%
Returns
ROA -9.1%
ROE -13.0%
ROIC -11.7%
Financial Health
Net Cash
¥396.28M ($58.41M)
Current Ratio 3.03
Interest Coverage -1,083.62
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the P...
Sector Healthcare
Industry Medical - Diagnostics & Research
Employees 667
IPO Date Jun 12, 2020
Website www.brbiotech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BNR